(PG) The Procter & Gamble Company BCG Matrix Research

US | Consumer Defensive | Household & Personal Products | NYSE
(PG) The Procter & Gamble Company BCG Matrix Research

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

(PG) The Procter & Gamble Company Bundle

Get Full Bundle:
$9 $5
$9 $5
$9 $5
$19 $9
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
Icon

Download Your Competitive Advantage

This The Procter & Gamble Company BCG Matrix helps you see how the company’s products or business units are positioned across Stars, Cash Cows, Question Marks, and Dogs, making it useful for strategy, portfolio review, and decision-making. What you see on this page is a real preview of the actual analysis, not just promotional text, so you can review the format and content before buying. Purchase the full version to get the complete ready-to-use report.

Icon

Stars

Icon

SK-II: prestige skincare in Asia

SK-II is a Star for The Procter & Gamble Company because it sits in premium skincare, one of the fastest-growing beauty niches in Asia. P&G’s FY2025 net sales were $84.3 billion, and the company kept backing SK-II with digital and retail spend to protect share in high-end face care. Its premium positioning gives it strong pricing power while category growth stays attractive.

Icon

Oral-B iO: premium electric toothbrushes

Oral-B iO fits a Star role in Procter & Gamble Company's BCG Matrix because it targets the premium oral-care tier, where consumers keep trading up to connected, rechargeable brushes. In fiscal 2025, Procter & Gamble Company reported $84.3 billion in net sales, and premium brushes like Oral-B iO support higher margins than standard brushes and toothpaste. To keep that share, Procter & Gamble Company still has to spend on innovation, media, and retail distribution.

Explore a Preview
Icon

Febreze: air care leader

Febreze remains a Star-like franchise for The Procter & Gamble Company because air care and odor control keep expanding, while its spray, plug-in, and car care lines give it broad shelf space and repeat use. In fiscal 2025, The Procter & Gamble Company reported net sales of $84.3 billion, and Home Care was one of its biggest pillars. That scale and visibility help Febreze defend share as demand for home-fragrance products grows.

Swiffer: disposable floor cleaning systems

Swiffer sits in the Star quadrant because it rides the convenience-led cleaning shift in mature markets, where P&G reported FY2025 net sales of $84.3 billion and organic sales grew 2%. Strong shelf space across mop pads, dusters, and refills keeps the brand visible, while repeat purchases support steady category share.

It is still a growth engine, but it needs constant ad spend and product updates to defend against private label and new formats.

  • High brand recognition
  • Strong retailer placement
  • Repeat refill demand
  • Needs fresh launches

Downy Unstopables: scent boosters

Downy Unstopables fits Star status because it sits in a premium laundry add-on niche that can outgrow basic detergent, while riding on The Procter & Gamble Company's $84.3B FY2025 scale and repeat household buys. It also needs steady ad spend and product updates to keep share.

  • Premium, repeat-purchase line
  • Backed by P&G fabric-care scale
  • Needs ongoing innovation
  • Star: high growth, high support
Icon

P&G’s Star Brands: SK-II, Oral-B iO, and Febreze Drive Growth

SK-II, Oral-B iO, and Febreze are The Procter & Gamble Company Stars: premium or fast-growing lines with strong share and room to expand. In FY2025, The Procter & Gamble Company posted $84.3 billion in net sales and 2% organic sales growth, so these brands still got heavy support. They win on pricing power, repeat use, and retail reach, but they need constant ad and innovation spend.

Brand Why Star FY2025 tie-in
SK-II Premium skincare growth Backed by spend
Oral-B iO Premium oral care Margin support
Febreze Repeat-use air care Scale in Home Care

What is included in the product

Detailed Word Document icon

Detailed Word Document

P&G BCG Matrix overview of key brands, showing Stars, Cash Cows, Question Marks, and Dogs.

Customizable Excel Spreadsheet icon

Editable Excel File

Quick BCG snapshot of P&G’s brands to spot cash cows, stars, and drags fast

References icon

Reference Sources

Provides a concise source trail for P&G claims, helping decision-makers verify data fast and trust the analysis.

Icon

Cash Cows

Icon

Tide: No. 1 U.S. laundry detergent

Tide is P&G's No. 1 U.S. laundry detergent and a classic Cash Cow. P&G's Fabric & Home Care segment generated about $29.0 billion in fiscal 2025 sales, with Tide helping defend strong share in a slow-growth category. That mix of scale, brand equity, and steady demand supports durable cash flow and margins.

Icon

Pampers: global diaper leader

Pampers is P&G's global diaper leader, and diapers sit in a mature market where birth rates do not drive fast growth. Even so, the brand benefits from repeat buying and premium pricing; P&G reported FY2025 net sales of $84.3 billion and free cash flow of $14.3 billion, showing the kind of steady cash Pampers helps support.

Explore a Preview
Icon

Gillette: blades and razors leader

Gillette remains a leader in razors and blades, and its blade refill model keeps cash coming in after the first razor sale. Shaving is a mature market, so volume growth is slower than newer personal-care lines; P&G reported fiscal 2025 net sales of $84.3 billion, with Grooming still a smaller but steady cash generator. Premium systems and replacement blades support recurring margins even when unit growth stays modest.

Crest: mature oral-care staple

Crest is a mature, high-penetration oral-care brand inside The Procter & Gamble Company’s $84.3 billion FY2025 portfolio, so it fits the Cash Cow slot. Toothpaste demand is steady, repeat-driven, and low-growth, but it keeps cash flowing with attractive margins and low capital needs. That makes Crest a reliable profit engine, even if it no longer drives big volume growth.

  • High household reach

  • Frequent repeat purchases

  • Low-growth category

  • Strong cash generation

Charmin: toilet paper scale brand

Charmin is a Cash Cow for The Procter & Gamble Company because tissue is an essential, low-growth category, and the brand sells into high-frequency repeat use. P&G reported fiscal 2025 net sales of $84.3 billion, and Charmin helps support that cash flow with a strong U.S. position and modest reinvestment needs.

  • Essential, low-growth tissue category
  • High-volume repeat household purchases
  • Strong U.S. scale and share
  • Steady cash, limited capex needs
Icon

P&G’s Cash Cows Keep the Cash Flowing

P&G's Cash Cows are Tide, Pampers, Gillette, Crest, and Charmin: mature brands in low-growth categories that still sell at scale. In fiscal 2025, The Procter & Gamble Company posted $84.3 billion in net sales and $14.3 billion in free cash flow, showing the cash these brands help generate.

Brand Role 2025 cue
Tide Laundry leader Scale cash flow
Pampers Diaper leader Repeat demand
Gillette Shaving leader Blade refills
Crest Oral care High penetration
Charmin Tissue leader Steady use

Preview the Actual Deliverable
The Procter & Gamble Company Reference Sources

You’re previewing the exact Procter & Gamble Company BCG Matrix report you’ll receive after purchase. What you see here is the final file—no demo version, no hidden changes. Once purchased, the full document is instantly available for download and use.

Explore a Preview
Icon

Dogs

Icon

Luvs: value diaper line

Luvs is P&G's value diaper line, but it sits far below Pampers in strategic weight. In P&G's fiscal 2025 business, net sales were about $84 billion, yet Luvs is not a separate growth driver. In a crowded, mature diaper market, its share and growth stay limited, so it fits the Dog quadrant.

Icon

Puffs: facial tissues with limited scale

Puffs sits in a slow-growth facial tissue market where a few large brands dominate, so it has limited room to scale. The Procter & Gamble Company reported $84.3 billion in fiscal 2025 net sales, but Puffs is not one of the company’s major cash engines like Tide or Pampers. With low share and weak growth, Puffs fits Dog status in the BCG Matrix.

Explore a Preview
Icon

Safeguard: legacy cleansing brand

Safeguard fits the Dog box: it is a legacy cleansing brand in a crowded, low-differentiation category, while P&G reported FY2025 net sales of $84.3 billion and only broad segment reporting, not Safeguard-led growth. It lacks the scale and pricing power of P&G flagships like Tide or Pampers.

In a market where share is won on price, scent, and distribution, Safeguard’s growth looks limited and its competitive edge thin. That makes it a weak capital user versus faster-growing P&G brands.

Rejoice: regional hair-care brand

Rejoice is a regional hair-care brand with far less global reach than P&G’s big names like Pantene and Head & Shoulders. In a mature mass hair-care market, where growth is slow and rivals fight on price and shelf space, that limited scale and modest share make Rejoice fit Dog territory.

P&G’s strength sits with global brands and larger ad budgets, while Rejoice is more exposed to local competition and weaker pricing power. In the BCG Matrix, a Dog usually means low growth and low relative share, so the brand is better managed for cash harvest than for heavy expansion.

  • Limited global reach
  • Low relative market share
  • Mature, slow-growing market
  • Best treated as a cash-cow drain to control

Aussie: niche hair-care label

Aussie is a niche hair-care brand in Procter & Gamble’s Beauty portfolio, and it sits in a crowded market where global names like L’Oréal and salon brands dominate shelf space. P&G reported fiscal 2025 net sales of $84.3 billion, but Aussie is not a major scale driver inside that mix. With limited scale and muted growth, it fits the BCG Dog box.

  • Small brand in a crowded category
  • Faces bigger global and salon rivals
  • Low scale, weak growth, Dog fit
Icon

P&G’s “Dog” Brands: Low Share, Low Growth, Little Lift

In P&G’s FY2025, net sales were $84.3 billion, but Dogs like Luvs, Puffs, Safeguard, Rejoice, and Aussie did not move the needle. Each sits in a mature, crowded category with low relative share and weak growth, so they fit the Dog box. These brands are better kept lean than funded for expansion.

Dog brand Fit
Luvs Low share, low growth
Puffs Slow tissue market
Safeguard Weak scale
Rejoice Regional niche
Aussie Small hair-care brand
Icon

Question Marks

Icon

Tide evo: new laundry format

Tide evo is still a small new-format bet, while Procter & Gamble’s Fabric & Home Care unit delivered about $29 billion in FY2025 sales, showing how far it is from core Tide scale. In a category that is still expanding, Tide evo has upside, but its share is not yet proven. That makes it a Question Mark: it needs more spend or clearer demand proof before it can move up.

Icon

Braun IPL: home hair-removal devices

Braun IPL sits in a growing premium home hair-removal niche, so the upside is real. In Procter & Gamble’s FY2025, net sales were $84.3 billion and organic sales rose 2%, but Braun still trails larger mass grooming franchises like Gillette. That mix of rising category demand and limited share fits a Question Mark.

Explore a Preview
Icon

GilletteLabs: premium heated razor line

GilletteLabs is P&G’s premium, innovation-led shaving line, and it fits a Question Mark because the niche is growing faster than basic razors but scale is still modest. P&G posted fiscal 2025 net sales of $84.3 billion, so it has the cash to keep funding the line. If GilletteLabs wins more premium share, it can move toward Star status; if not, it stays a small but costly bet.

Pampers Pure Protection: eco-premium diapers

Pampers Pure Protection sits in the faster-growing eco-premium baby-care niche, but it still trails the scale of the core Pampers franchise. That makes it a Question Mark in The Procter & Gamble Company BCG Matrix: the market is attractive, but share is still being built. P&G reported FY2025 net sales of about $84.3 billion, while this sub-brand remains a smaller, newer growth bet.

  • Eco-premium demand is growing faster.
  • Core Pampers still leads by scale.
  • Share gains decide its future.

Always Discreet: adult incontinence growth niche

Always Discreet fits a Question Mark: adult incontinence demand is expanding as the global 65+ population rises to about 1.1 billion in 2025, and P&G reported net sales of $84.0 billion in fiscal 2025. Still, P&G is not as dominant here as in Tide or Pampers, so share gains matter more than scale.

  • Growing aging-population category
  • Attractive long-term demand
  • Lower P&G share than core staples
  • Upside depends on market-share gains
Icon

P&G’s Small-Bet Brands: Growth Options With Room to Prove Demand

P&G’s Question Marks are small bets in growing niches, including Tide evo, Braun IPL, GilletteLabs, Pampers Pure Protection, and Always Discreet. In FY2025, Procter & Gamble posted $84.3 billion in net sales and 2% organic sales growth, so it can fund them. Their share is still below core brands, so the next step is proof of demand.

Brand Signal
Tide evo New format, low scale
Braun IPL Premium niche, share build
GilletteLabs Innovation bet
Pampers Pure Protection Eco-premium growth
Always Discreet Ageing-demand upside

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.